In the patients that have been clearly diagnosed with D2L2AD the consistent clinical manifestations include severe neonatal epileptic encephalopathy, often accompanied by respiratory insufficiency requiring artificial ventilation
In 2010, the Working Group on Consensus and Clinical Guidelines of the Spanish Society of Diabetes (SED) published a consensus on drug treatment in type 2 diabetes mellitus (T2DM) which was approved by different scientific bodies.1 The Working Group thought that it would be useful to publish a consensus document specifically addressed to insulin therapy in T2DM
MarchettiVMenghiniRRizzaSVivantiAFecciaTLauroDet al
It gives franchisees an edge because they have a ready market
Gastrointestinal effects are among the most frequently reported adverse events with GLP-1 therapies and typically include nausea, vomiting, diarrhea, constipation, and abdominal pain
Selecting the right GLP-1 supplement for private labeling or bulk purchase requires a strategic, data-driven approach
